On Sept. 4, 2020, CureVac announced that it had received notification from the German Federal Ministry of Education…
On Sept. 3, 2020, RedHill Biopharma announced the selection of opaganib, a proprietary, first-in-class, orally-administered, sphingosine kinase-2 (SK2)…
On Sept. 3, 2020, as part of the ongoing randomised, controlled clinical trials of the AstraZeneca Oxford coronavirus…
On Sept. 3, 2020, the U.S Department of Defense announced that five locations were identified to participate in…
On Sept. 3, 2020, Oregon Health & Science University (OHSU) announced that for the first time, early research…
On Sept. 2, 2020, Novavax announced the publication in The New England Journal of Medicine of Phase 1…
On Sept. 1, 2020, Entos Pharmaceuticals announce the launch of its San Diego-based spinout company Aegis Life, dedicated…
On Sept. 1, 2020, MediciNova announced development progress on its intranasal SARS-CoV-2 vaccine for COVID-19 utilizing BC-PIV, a…
On Sept. 1, 2020, HDT Bio received a notice of award from the National Institute of Allergy and…
On Aug. 31, 2020, a multi-site, Phase 3 clinical trial evaluating an investigational COVID-19 vaccine known as AZD1222…
On Aug. 31, 2020, AstraZeneca announced that the COVID-19 vaccine AZD1222 expanded into U.S. Phase III clinical trial…
On Aug. 31, 2020, Novavax announced it had reached an agreement in principle with the Government of Canada…
On Aug. 28, 2020, Moderna confirmed that the Company is engaged in discussions with the Ministry of Health,…
On Aug. 27, 2020, Pfizer and Shanghai Fosun Pharmaceutical announced an intended collaboration to supply 10 million doses…
On Aug. 26, 2020, VBI Vaccines announced data from three preclinical mouse studies conducted to enable selection of…
On Aug. 26, 2020, UConn announced that Thanh Duc Nguyen, Assistant Professor in the Departments of Mechanical Engineering…
On Aug. 26, 2020, Altimmune announced additional positive results from the preclinical studies of its single-dose intranasal COVID-19…
On Aug. 25, 2020, the independent Africa Regional Certification Commission (ARCC) for Polio Eradication officially declared that the…
On Aug. 25, 2020, Sinovac Biotech announced it had signed two agreements in Hainan, China with PT Bio…
On Aug. 25, 2020, Intravacc announced that it had partnered with American, Buffalo, NY, based Therapyx, to further…
On Aug. 25, 2020, Codex DNA announced critical advancements in its development of the Digital-to-Biological Converterï¾™ (DBC) platform….
On Aug. 24, 2020, the World Heath Organization (WHO) reported that 172 economies were engaged in discussions to…
On Aug. 24 2020, NantKwest and ImmunityBio announced an agreement to jointly develop, manufacture, market, and commercialize therapeutics…
On Aug. 24, 2020, Novavax announced that the first volunteers were enrolled in the Phase 2 portion of…
On Aug. 24, 2020, Catalent announced that it had contracted to provide drug substance manufacturing to AstraZeneca for…
On Aug. 20, 2020, CureVac and the European Commission (EC) concluded exploratory talks outlining an Advanced Purchase Agreement…
On Aug. 20, 2020, Sorrento Therapeutics and SmartPharm Therapeutics announced the signing of a merger agreement under which…
On Aug. 20, 2020, Oragenics and Avid Bioservices announced a process development and drug substance manufacturing agreement. Avid…
On Aug. 20, 2020, Pfizer and BioNTech shared additional Phase 1 safety and immunogenicity data from their U.S….
On Aug. 19, 2020, an experimental vaccine was reported to be effective at preventing pneumonia in mice infected…